Salarius Pharmaceuticals Inc.
13F holders, Q3 2025 (September 30)5holders
$3.68avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding Salarius Pharmaceuticals Inc. in their 13F filings. The largest holders were Advisory Services Network, LLC ($2K), UBS Group AG ($106) and Osaic Holdings, Inc. ($17).
- Company
- Salarius Pharmaceuticals Inc.
- CUSIP
- 79400X503
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2K |
| Exits | 0 | $0 |
Ownership 5 holders
| Advisory Services Network, LLC | 0.00% | New | 500 | $2K |
| UBS Group AG | 0.00% | New | 29 | $106 |
| Osaic Holdings, Inc. | 0.00% | New | 3 | $17 |
| Bank of America Corp. | 0.00% | New | 4 | $15 |
| Danske Bank A/S | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is SALARIUS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Salarius Pharmaceuticals Inc. the manager owns.